BL
DNTH icon

Bleichroeder LP’s Dianthus Therapeutics DNTH Stock Holding History

Bleichroeder LP’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,664
Closed -$137K – 83
2022
Q4 		$137K Sell
21,664
-8,611
-28% -$152K 0.03% 50
2022
Q3 		$683K Hold
30,275
– – 0.14% 39
2022
Q2 		$581K Hold
30,275
– – 0.12% 42
2022
Q1 		$1.41M Hold
30,275
– – 0.25% 41
2021
Q4 		$2.15M Buy
30,275
+3,125
+12% +$314K 0.34% 44
2021
Q3 		$3.16M Hold
27,150
– – 0.51% 35
2021
Q2 		$4.25M Hold
27,150
– – 0.64% 32
2021
Q1 		$5.14M Hold
27,150
– – 0.87% 24
2020
Q4 		$3.41M Buy
27,150
+5,158
+23% +$585K 0.66% 25
2020
Q3 		$2.39M Hold
21,992
– – 0.43% 33
2020
Q2 		$2.64M Buy
21,992
+6,250
+40% +$881K 0.47% 34
2020
Q1 		$1.58M Buy
+15,742
New +$2.92M 0.41% 38

Other funds holding DNTH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return